BioArctic is a Swedish biopharmaceutical company that researches and develops treatments for neurodegenerative diseases. Its work centres on antibodies and other therapies aimed at conditions such as Alzheimer's disease and Parkinson's disease. The company carries out its own drug discovery and development and works with larger pharmaceutical partners on later-stage programmes. BioArctic is based in Stockholm, Sweden, and its customers and collaborators are mainly pharmaceutical companies and research organisations involved in neuroscience.
The shares are listed on the Stockholm Exchange in Sweden under the code BIOA-B, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #338 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendFair
55/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-8.8%
From 52-week high-20.2%
MomentumFair
53/100
Typical recent returns for this exchange.
See the numbers →
3-month return-6.2%
6-month return-8.5%
12-month, skipping last month6.3%
Stability (higher is calmer)Strong
72/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)42.2%
Worst drawdown, 1 year (smaller is calmer)-22.5%
LiquidityStrong
91/100
Trades actively.
See the numbers →
Avg daily value traded46.94M SEK
Zero-volume days0.0%
IncomeWeak
5/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.7%
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 255.49 – 362.25Daily closes, split-adjusted
Signals
50-day average317.14
200-day average316.92
Golden/death cross (60d)Golden, 45 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)8.97
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
293.3
Bearish
EMA 10
294.1
Bearish
SMA 20
302.6
Bearish
EMA 20
300.8
Bearish
SMA 50
317.1
Bearish
EMA 50
310.4
Bearish
SMA 100
314.5
Bearish
EMA 100
313.6
Bearish
SMA 200
316.9
Bearish
EMA 200
307.7
Bearish
Oscillators (daily)
RSI (14)
37.36
Neutral
MACD (12, 26)
-8.26
Bearish
Momentum (12)
-5.86
Bearish
Stochastic %K (14)
19.86
Bullish
Williams %R (14)
-80.14
Bullish
CCI (20)
-103.4
Bullish
Pivot points (classic, last session)
S3
277.5
S2
280.3
S1
284.7
Pivot
287.5
R1
291.9
R2
294.7
R3
299.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.00 SEK
Yield on today's price
0.69%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
29 May 2026
2.0000
10 May 2019
1.5000
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
